NIKKEI 225
38,354.34 +151.97 (+0.40%) HANG SENG
18,448.31 +134.45 (+0.73%) CRUDE OIL
79.31 +0.32 (+0.41%) GOLD FUTURES
2,316.70 -5.60 (-0.24%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,197.27 -957.09 (-1.91%)
Travere Therapeutics, Inc. (TVTX)
After hours:
| Previous close | 6.75 |
| Open | 6.77 |
| Bid | 6.79 x 500 |
| Ask | 6.86 x 200 |
| Day's range | 6.49 - 6.93 |
| 52-week range | 5.12 - 19.54 |
| Volume | |
| Avg. volume | 1,275,980 |
| Market cap | 519.2M |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.41 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.13 |
GlobeNewswireTravere Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences: BofA Securities Health Care Conference Wednesday, May 15, 2024, at 8:00 a.m. PT Jefferies Global Healthcare ConferenceWednesday, June 5, 2024, at 3:00 p.m. ET Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will b
Simply Wall St.Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term
With the business potentially at an important milestone, we thought we'd take a closer look at Travere Therapeutics...
- GuruFocus.com
Travere Therapeutics Inc (TVTX) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
Discover how Travere Therapeutics Inc (TVTX) achieved a robust revenue increase and navigated regulatory landscapes in the first quarter of 2024.
